VB website - https://www.vbllc.com
I am going to share thoughts on this interesting acquisition. I don't have any inside information and I could be completely wrong, but this is what I see.
In a move that caught many by surprise, Stryker has decided to divest its spine division to Viscogliosi Brothers, LLC (VB). Here's my take on what this could mean for the future of spine care, investment, and market dynamics.
Stryker's Perspective
Stryker's decision to sell off its spine division is, in my view, a strategic masterstroke. The company has been posting impressive growth across its other divisions, boasting an 11% annual revenue increase on a $22 billion business. However, the spine division has been somewhat of a laggard, with stagnant growth on a $700 million revenue stream, essentially pulling down the overall performance. This sale echoes Zimmer Biomet's (ZB) past decisions to spin off its spine and dental divisions, which were also underperforming segments.
VB's Bold Move
From VB's angle, this acquisition marks what could be their most significant play in PE-like deal to date. How they managed to pull off the financial leverage for such a deal is beyond me, but it's an audaci...
